Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (4977)	12/2/1997 5:23:00 PM
From: opalapril	Read Replies (1) \| Respond to of 17367

>>How does The Lancet or any similar journal work? * * * Is it possible that having received his response on the first article he was asked to opine on the yet to appear article also? Or was he sent an advance copy of the second article prior to publication * * *<< I have no direct knowledge of Lancet, but as to similar articles and from what I do know of Lancet's peer review publication process, my answer would be -- Yes, either or both. I have observed Lancet takes care with letters, though not as much as with articles, often requiring they be accompanied by footnotes, professional references, etc. Flattered you would ask, and disturbed that you may have mistaken me for the other Opal who co-authors some XOMA papers. She is not me.